Brookdale Reports Q4 Revenue of $754.09M, Adjusted EBITDA of $105.6M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 13 hours ago
0mins
Should l Buy BKD?
Reports Q4 revenue $754.09M vs. $780.95M last year. Reports Q4 adjusted EBITDA $105.6M vs. $98.5M last year. "Brookdale's Q4 results continued the positive momentum displayed throughout 2025, as we position Brookdale to capitalize on increasing industry demand in a suppressed supply growth environment," said CEO Nick Stengle. "We are pleased with the results we delivered as we focus on operational excellence and delivering shareholder value. We are excited about the opportunities in 2026 for further progress, which is demonstrated by our recently provided annual guidance of mid-teens year over year growth in Adjusted EBITDA for our ongoing portfolio and 8% to 9% RevPAR growth."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BKD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BKD
Wall Street analysts forecast BKD stock price to fall
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.640
Low
13.00
Averages
13.33
High
14.00
Current: 16.640
Low
13.00
Averages
13.33
High
14.00
About BKD
Brookdale Senior Living Inc. is a premier operator of senior living communities, operating and managing 665 communities in 41 states. The Company operates independent living, assisted living, memory care, and continuing care retirement communities. It operates through three segments: Independent Living; Assisted Living and Memory Care, Continuing Care Retirement Communities (CCRCs). Its Independent Living segment includes owned or leased communities that are primarily designed for middle to upper-income seniors who desire to live in a residential setting that feels like home, without the efforts of ownership. Its Assisted Living and Memory Care segment includes owned or leased communities that offer housing and 24-hour assistance with activities of daily living for the Company's residents. The CCRCs segment includes large owned or leased communities that offer a variety of living arrangements and services to accommodate a broad spectrum of physical ability and healthcare needs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Brookdale Senior Living Set to Announce Q4 Earnings on February 18
- Earnings Announcement: Brookdale Senior Living (BKD) is set to release its Q4 2023 earnings report on February 18 after market close, with consensus EPS estimates at -$0.17, reflecting a 54.1% year-over-year improvement, indicating potential recovery in profitability.
- Revenue Expectations: Analysts forecast Q4 revenue at $770.48 million, representing a 1.3% year-over-year decline, highlighting challenges in revenue growth amid a competitive senior care market.
- Estimate Revision Dynamics: Over the past three months, EPS estimates have seen one upward and one downward revision, while revenue estimates have also experienced similar adjustments, suggesting mixed market sentiment regarding Brookdale's financial outlook.
- Investor Day Insights: During its Analyst/Investor Day, Brookdale showcased improvements in operational leverage, signaling a significant strategic pivot aimed at enhancing financial performance and competitive positioning in the market.
See More
Brookdale Senior Living Reports Q4 Earnings Results
- Earnings Report: Brookdale Senior Living reported a Q4 GAAP EPS of -$0.17, aligning with market expectations, indicating ongoing challenges in profitability amidst a tough market.
- Revenue Decline: The company's Q4 revenue of $754.09 million represents a 3.4% year-over-year decline, missing analyst expectations by $16.39 million, reflecting weakened market demand and intensified competition.
- Operational Leverage Signals: Despite the revenue drop, Brookdale is actively seeking to pivot its strategy by enhancing operational efficiencies, indicating a proactive approach to adapt to market changes.
- Future Outlook: With occupancy data for December 2025 set to be released soon, investors are keenly watching its potential impact on future performance, particularly regarding the company's adaptability in the current economic landscape.
See More
Brookdale Reports Strong 2025 Financial Results with Positive Outlook
- Revenue Growth: Brookdale's resident fee revenue reached $304.27 million in 2025, up 2.4% from $297.21 million in 2024, indicating stable demand and revenue growth potential in the senior housing market.
- Adjusted EBITDA Increase: The company reported an Adjusted EBITDA of $457.84 million for 2025, an 18.5% increase from $386.27 million in 2024, reflecting significant improvements in operational efficiency and cost control, enhancing future profitability.
- Occupancy Rate Improvement: The average occupancy rate for 2025 was 80.9%, up 230 basis points from 78.6% in 2024, demonstrating the company's success in attracting and retaining residents, further solidifying its market position.
- Positive Future Outlook: Brookdale anticipates a RevPAR growth rate of 8% to 9% for 2026 and plans to generate approximately $200 million in cash proceeds from the sale of 29 communities (2,364 units), showcasing strategic decisions to optimize its asset portfolio and enhance financial flexibility.
See More
Brookdale Senior Living to Release Q4 2025 Financial Results
- Earnings Release Schedule: Brookdale Senior Living is set to release its Q4 and full-year 2025 financial results after market close on February 18, 2026, which is expected to provide investors with critical financial data and future outlook.
- Conference Call Timing: The company will hold a conference call on February 19, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time) to discuss the financial results, aiming to enhance communication and transparency with investors.
- Webcast Availability: Investors can access the live webcast of the conference call at brookdaleinvestors.com, ensuring they download the necessary software beforehand to facilitate smooth listening, reflecting the company's emphasis on technological convenience.
- Community Operations Scale: As of December 31, 2025, Brookdale operates 584 communities across 41 states, serving approximately 51,000 residents, showcasing its leadership position and market impact in the senior living community sector.
See More
Brookdale to Release Q4 and Full Year 2025 Financial Results
- Earnings Release Schedule: Brookdale Senior Living will release its fourth quarter and full year 2025 financial results after market close on February 18, 2026, providing investors with critical financial data and operational performance insights.
- Conference Call Timing: The company will hold a conference call on February 19, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time) to discuss the financial results, aiming to enhance communication and transparency with investors.
- Webcast Access: Investors can access the live webcast of the conference call at brookdaleinvestors.com, ensuring they download the necessary software ahead of time for a smooth listening experience, thereby improving engagement.
- Company Overview: Brookdale Senior Living operates 584 communities across the U.S., serving approximately 51,000 residents, and is committed to enhancing seniors' quality of life through compassionate care and expertise, showcasing its leadership in the senior living sector.
See More
Warning Signs for Overbought Healthcare Stocks
- Overbought Signals: As of February 2, 2026, three stocks in the healthcare sector are showing overbought signals with RSI values exceeding 70, indicating potential short-term pullback risks that investors should be cautious about.
- Brookdale Senior Living: This company's stock is in an overbought state with an RSI of 80.4, reflecting strong price momentum but also suggesting possible price adjustment risks, prompting investors to monitor market developments closely.
- Amicus Therapeutics Acquisition: Amicus Therapeutics announced its acquisition by BioMarin, with its stock price surging approximately 139% over the past six months to $14.29, while its RSI of 80.4 indicates strong market interest but also warns of potential corrections.
- Mirum Pharmaceuticals Performance: Mirum Pharmaceuticals is also in an overbought condition, and investors should pay attention to its RSI and market performance to assess future investment risks and opportunities.
See More
Brookdale Senior Living Set to Announce Q4 Earnings on February 18
- Earnings Announcement: Brookdale Senior Living (BKD) is set to release its Q4 2023 earnings report on February 18 after market close, with consensus EPS estimates at -$0.17, reflecting a 54.1% year-over-year improvement, indicating potential recovery in profitability.
- Revenue Expectations: Analysts forecast Q4 revenue at $770.48 million, representing a 1.3% year-over-year decline, highlighting challenges in revenue growth amid a competitive senior care market.
- Estimate Revision Dynamics: Over the past three months, EPS estimates have seen one upward and one downward revision, while revenue estimates have also experienced similar adjustments, suggesting mixed market sentiment regarding Brookdale's financial outlook.
- Investor Day Insights: During its Analyst/Investor Day, Brookdale showcased improvements in operational leverage, signaling a significant strategic pivot aimed at enhancing financial performance and competitive positioning in the market.
See More
Brookdale Senior Living Reports Q4 Earnings Results
- Earnings Report: Brookdale Senior Living reported a Q4 GAAP EPS of -$0.17, aligning with market expectations, indicating ongoing challenges in profitability amidst a tough market.
- Revenue Decline: The company's Q4 revenue of $754.09 million represents a 3.4% year-over-year decline, missing analyst expectations by $16.39 million, reflecting weakened market demand and intensified competition.
- Operational Leverage Signals: Despite the revenue drop, Brookdale is actively seeking to pivot its strategy by enhancing operational efficiencies, indicating a proactive approach to adapt to market changes.
- Future Outlook: With occupancy data for December 2025 set to be released soon, investors are keenly watching its potential impact on future performance, particularly regarding the company's adaptability in the current economic landscape.
See More
Brookdale Reports Strong 2025 Financial Results with Positive Outlook
- Revenue Growth: Brookdale's resident fee revenue reached $304.27 million in 2025, up 2.4% from $297.21 million in 2024, indicating stable demand and revenue growth potential in the senior housing market.
- Adjusted EBITDA Increase: The company reported an Adjusted EBITDA of $457.84 million for 2025, an 18.5% increase from $386.27 million in 2024, reflecting significant improvements in operational efficiency and cost control, enhancing future profitability.
- Occupancy Rate Improvement: The average occupancy rate for 2025 was 80.9%, up 230 basis points from 78.6% in 2024, demonstrating the company's success in attracting and retaining residents, further solidifying its market position.
- Positive Future Outlook: Brookdale anticipates a RevPAR growth rate of 8% to 9% for 2026 and plans to generate approximately $200 million in cash proceeds from the sale of 29 communities (2,364 units), showcasing strategic decisions to optimize its asset portfolio and enhance financial flexibility.
See More
Brookdale Senior Living to Release Q4 2025 Financial Results
- Earnings Release Schedule: Brookdale Senior Living is set to release its Q4 and full-year 2025 financial results after market close on February 18, 2026, which is expected to provide investors with critical financial data and future outlook.
- Conference Call Timing: The company will hold a conference call on February 19, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time) to discuss the financial results, aiming to enhance communication and transparency with investors.
- Webcast Availability: Investors can access the live webcast of the conference call at brookdaleinvestors.com, ensuring they download the necessary software beforehand to facilitate smooth listening, reflecting the company's emphasis on technological convenience.
- Community Operations Scale: As of December 31, 2025, Brookdale operates 584 communities across 41 states, serving approximately 51,000 residents, showcasing its leadership position and market impact in the senior living community sector.
See More
Brookdale to Release Q4 and Full Year 2025 Financial Results
- Earnings Release Schedule: Brookdale Senior Living will release its fourth quarter and full year 2025 financial results after market close on February 18, 2026, providing investors with critical financial data and operational performance insights.
- Conference Call Timing: The company will hold a conference call on February 19, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time) to discuss the financial results, aiming to enhance communication and transparency with investors.
- Webcast Access: Investors can access the live webcast of the conference call at brookdaleinvestors.com, ensuring they download the necessary software ahead of time for a smooth listening experience, thereby improving engagement.
- Company Overview: Brookdale Senior Living operates 584 communities across the U.S., serving approximately 51,000 residents, and is committed to enhancing seniors' quality of life through compassionate care and expertise, showcasing its leadership in the senior living sector.
See More
Warning Signs for Overbought Healthcare Stocks
- Overbought Signals: As of February 2, 2026, three stocks in the healthcare sector are showing overbought signals with RSI values exceeding 70, indicating potential short-term pullback risks that investors should be cautious about.
- Brookdale Senior Living: This company's stock is in an overbought state with an RSI of 80.4, reflecting strong price momentum but also suggesting possible price adjustment risks, prompting investors to monitor market developments closely.
- Amicus Therapeutics Acquisition: Amicus Therapeutics announced its acquisition by BioMarin, with its stock price surging approximately 139% over the past six months to $14.29, while its RSI of 80.4 indicates strong market interest but also warns of potential corrections.
- Mirum Pharmaceuticals Performance: Mirum Pharmaceuticals is also in an overbought condition, and investors should pay attention to its RSI and market performance to assess future investment risks and opportunities.
See More
